India News | Press Trust of India | Monday February 14, 2022
An expert panel of the country's central drug authority on Monday recommended granting restricted emergency use authorisation to Biological E'sCOVID-19 vaccine, Corbevax, for age group 12 to 18 years subject to certain conditions, sources said.
www.ndtv.com